Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2018-08-29 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
MAJOR TRANSACTION ACQUISITION OF 5.11% EQUITY INTEREST IN TARGET COMPANY
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Overseas Chinese Town (Asia) Holdings Limited dated 30 August 2018, concerning a major transaction involving the acquisition of a 5.11% equity interest in a target company. It includes detailed information such as definitions, a letter from the board, terms of the equity transfer agreements, consideration, payment terms, and financial information appendices. The document is comprehensive and lengthy (15,000 characters), containing substantive financial and transaction details, management discussion, and analysis. It is not merely an announcement or a brief summary but a full circular providing detailed information to shareholders about a major transaction requiring their approval. This type of document is typically classified as a Proxy Solicitation & Information Statement (PSI), as it is sent to shareholders to provide information and request votes for the transaction approval. It is not an Annual Report, Earnings Release, or Regulatory Filing, nor is it a simple announcement or certification. Therefore, the appropriate classification is PSI with high confidence.
2018-08-29 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notice of a board meeting scheduled to consider and approve the interim results for the six months ended 30 June 2018 and possibly declare an interim dividend. It is a short announcement informing about the meeting date and agenda, without containing any actual financial data or detailed report. The document length is only 1511 characters, which is quite short and typical for a meeting notice. According to the rules, such a notice is not the interim report itself but an announcement related to the meeting where the report will be discussed. Therefore, it should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories like Interim Report (IR) or Earnings Release (ER).
2018-08-17 English
GRANT OF WAIVER UNDER RULE 14.41(a) OF THE LISTING RULES
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a waiver granted under Rule 14.41(a) of the Listing Rules by the Stock Exchange of Hong Kong. It references previous announcements and the delay in despatch of a circular related to an acquisition. The document is short (2148 characters) and primarily informs about the waiver and the condition to despatch the circular by a certain date. It does not contain financial statements, detailed financial data, or the actual circular or report itself. This fits the profile of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-08-03 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 July 2018
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/07/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, and other share-related activities. The content is focused on changes in the company's capital structure and share issuance activities during a specific month. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory filing reporting share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. It is not a proxy, AGM material, or voting result announcement. The document is a regulatory announcement about capital changes but does not announce a new share issue or capital change event per se; rather, it reports monthly movements. Given the detailed nature and regulatory submission, it fits best under 'Regulatory Filings' (RNS) as a general compliance report on share capital movements that does not fit other more specific categories like SHA (Share Issue/Capital Change) which usually covers announcements of new share issues or capital changes, not monthly returns. Confidence is high due to clear document purpose and content.
2018-08-02 English
DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO CORNERSTONE INVESTMENT IN E-HOUSE (CHINA) ENTERPRISE HOLDINGS LIMITED
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a delay in the despatch of a circular related to a major transaction (cornerstone investment). It references a previous announcement and discusses compliance with Listing Rules and postponement of the circular's despatch date. The document is short (1956 characters) and serves as a regulatory update about timing and compliance rather than the actual transaction details or financial data. It does not contain financial statements, detailed transaction terms, or full report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance updates that do not fit other categories.
2018-07-26 English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 5.11% EQUITY INTEREST IN TARGET COMPANY
Report Publication Announcement Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding a further delay in the despatch of a circular related to a major transaction (acquisition of equity interest). It references previous announcements and the expected date for the circular, but does not contain the circular itself or detailed financial data. The document is short (2308 characters) and serves as a notification about the delay in sending the circular, which is a report publication announcement type of document. Therefore, it fits the category of Report Publication Announcement (RPA).
2018-07-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.